Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Duloxetine Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 20mg Capsules
  • 1.4.3 30mg Capsules
  • 1.4.4 40mg Capsules
  • 1.4.5 60mg Capsules
• 1.5 Market by Application
  • 1.5.1 Global Duloxetine Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Duloxetine Market Size
• 2.2 Duloxetine Growth Trends by Regions
  • 2.2.1 Duloxetine Market Size by Regions (2014-2025)
  • 2.2.2 Duloxetine Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Duloxetine Market Size by Manufacturers
  • 3.1.1 Global Duloxetine Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Duloxetine Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Duloxetine Market Concentration Ratio (CR5 and HHI)
• 3.2 Duloxetine Key Players Head office and Area Served
• 3.3 Key Players Duloxetine Product/Solution/Service
• 3.4 Date of Enter into Duloxetine Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Duloxetine Market Size by Type (2014-2019)
• 4.2 Global Duloxetine Market Size by Application (2014-2019)

5 United States

• 5.1 United States Duloxetine Market Size (2014-2019)
• 5.2 Duloxetine Key Players in United States
• 5.3 United States Duloxetine Market Size by Type
• 5.4 United States Duloxetine Market Size by Application

6 Europe

• 6.1 Europe Duloxetine Market Size (2014-2019)
• 6.2 Duloxetine Key Players in Europe
• 6.3 Europe Duloxetine Market Size by Type
• 6.4 Europe Duloxetine Market Size by Application

7 China

• 7.1 China Duloxetine Market Size (2014-2019)
• 7.2 Duloxetine Key Players in China
• 7.3 China Duloxetine Market Size by Type
• 7.4 China Duloxetine Market Size by Application

8 Japan

• 8.1 Japan Duloxetine Market Size (2014-2019)
• 8.2 Duloxetine Key Players in Japan
• 8.3 Japan Duloxetine Market Size by Type
• 8.4 Japan Duloxetine Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Duloxetine Market Size (2014-2019)
• 9.2 Duloxetine Key Players in Southeast Asia
• 9.3 Southeast Asia Duloxetine Market Size by Type
• 9.4 Southeast Asia Duloxetine Market Size by Application

10 India

• 10.1 India Duloxetine Market Size (2014-2019)
• 10.2 Duloxetine Key Players in India
• 10.3 India Duloxetine Market Size by Type
• 10.4 India Duloxetine Market Size by Application

11 Central & South America

• 11.1 Central & South America Duloxetine Market Size (2014-2019)
• 11.2 Duloxetine Key Players in Central & South America
• 11.3 Central & South America Duloxetine Market Size by Type
• 11.4 Central & South America Duloxetine Market Size by Application

12 International Players Profiles

• 12.1 Eli Lilly
  • 12.1.1 Eli Lilly Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Duloxetine Introduction
  • 12.1.4 Eli Lilly Revenue in Duloxetine Business (2014-2019)
  • 12.1.5 Eli Lilly Recent Development
• 12.2 Teva
  • 12.2.1 Teva Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Duloxetine Introduction
  • 12.2.4 Teva Revenue in Duloxetine Business (2014-2019)
  • 12.2.5 Teva Recent Development
• 12.3 Lupin
  • 12.3.1 Lupin Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Duloxetine Introduction
  • 12.3.4 Lupin Revenue in Duloxetine Business (2014-2019)
  • 12.3.5 Lupin Recent Development
• 12.4 Sun Pharma
  • 12.4.1 Sun Pharma Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Duloxetine Introduction
  • 12.4.4 Sun Pharma Revenue in Duloxetine Business (2014-2019)
  • 12.4.5 Sun Pharma Recent Development
• 12.5 Zydus Pharmaceuticals
  • 12.5.1 Zydus Pharmaceuticals Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Duloxetine Introduction
  • 12.5.4 Zydus Pharmaceuticals Revenue in Duloxetine Business (2014-2019)
  • 12.5.5 Zydus Pharmaceuticals Recent Development
• 12.6 Torrent Pharmaceuticals
  • 12.6.1 Torrent Pharmaceuticals Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Duloxetine Introduction
  • 12.6.4 Torrent Pharmaceuticals Revenue in Duloxetine Business (2014-2019)
  • 12.6.5 Torrent Pharmaceuticals Recent Development
• 12.7 Sandoz
  • 12.7.1 Sandoz Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Duloxetine Introduction
  • 12.7.4 Sandoz Revenue in Duloxetine Business (2014-2019)
  • 12.7.5 Sandoz Recent Development
• 12.8 Aurobindo Pharma
  • 12.8.1 Aurobindo Pharma Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Duloxetine Introduction
  • 12.8.4 Aurobindo Pharma Revenue in Duloxetine Business (2014-2019)
  • 12.8.5 Aurobindo Pharma Recent Development
• 12.9 Apotex
  • 12.9.1 Apotex Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Duloxetine Introduction
  • 12.9.4 Apotex Revenue in Duloxetine Business (2014-2019)
  • 12.9.5 Apotex Recent Development
• 12.10 Breckenridge
  • 12.10.1 Breckenridge Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Duloxetine Introduction
  • 12.10.4 Breckenridge Revenue in Duloxetine Business (2014-2019)
  • 12.10.5 Breckenridge Recent Development
• 12.11 MACLEODS
• 12.12 Ajanta Pharma
• 12.13 CSPC Ouyi Pharm
• 12.14 Jiangsu Nhwa Pharmaceutical

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Duloxetine, sold under the brand name Cymbalta among others, is a medication mostly used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain.
In 2018, the global Duloxetine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Duloxetine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Duloxetine development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Teva
Lupin
Sun Pharma
Zydus Pharmaceuticals
Torrent Pharmaceuticals
Sandoz
Aurobindo Pharma
Apotex
Breckenridge
MACLEODS
Ajanta Pharma
CSPC Ouyi Pharm
Jiangsu Nhwa Pharmaceutical

Market segment by Type, the product can be split into
20mg Capsules
30mg Capsules
40mg Capsules
60mg Capsules

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Duloxetine status, future forecast, growth opportunity, key market and key players.
To present the Duloxetine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Duloxetine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.